R9U2.F Green Thumb Industries Inc

Healthcare Pharmaceuticals Frankfurt Exchange
6.28 EUR
Close of Nov 12, 2026
4.40 8.95
Market cap
EUR 1.24B
P/E
15.8x
P/B
0.75x
ROE
1.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is R9U2.F undervalued?

Graham number
Price6.28
Graham value8.65
Discount27.5%

R9U2.F trades 27.5% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Green Thumb Industries Inc fundamental analysis

No fundamental analysis for Green Thumb Industries Inc yet.

Green Thumb Industries Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Green Thumb Industries Inc

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, i…

Full company profile